Bristol Myers Squibb results beat expectations as newer drugs deliver growth

Bristol Myers Squibb Co. on Friday reported second-quarter results that topped analysts’ estimates as some of the company’s newer drugs began to hit their stride.

Previous post 3M’s stock surges toward a 20-month high after earnings beat, raised outlook
Next post Hedge-fund giant Man says assets reach record levels